[Local use of recombinant interleukin-1 beta in the complex treatment of patients with acute lung abscess].
An analysis of results of examination and treatment of 59 patients with a prolonged duration of acute abscesses of the lungs has shown the influence of immune disorders on the dynamics of the development and outcome of pyo-destructive disease in the lung. The indications to local immunosubstituting therapy were determined. A new original method of administration and a scheme of prescription of the medicine Betaleukin are proposed. Clinical efficiency of the method proposed is shown. The local immunocorrection used in the complex treatment of patients with acute abscesses of the lungs allows to get recovery of 89% of the patients.
Bisenkov
L N
LN
Simbirtsev
A S
AS
Zolotarev
D V
DV
Salamatov
A V
AV
Variushina
E A
EA
D000208:Acute Disease; D000328:Adult; D000368:Aged; D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D006801:Humans; D007375:Interleukin-1 / Q000008:administration & dosage*; D008169:Lung Abscess / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D008875:Middle Aged; D008962:Models, Theoretical; D009504:Neutrophils / Q000276:immunology; D010587:Phagocytosis; D011994:Recombinant Proteins; D013997:Time Factors
D007375:Interleukin-1; D011994:Recombinant Proteins
Mestnoe primenenie rekombinantnogo interleĭkina-1beta v kompleksnom lechenii bol'nykh s ostrymi abstsessami legkikh.